A follow-on share sale of up to HK$2.1bn (US$266m) has been launched in Hong Kong-listed Genscript Biotech.

就是找高盛，小摩帮忙，先旧后新快速增发21亿元股份。一般是不会披露认购方的。跟强生没一毛钱关系 不用yy了